The customer contacted siemens customer care center (ccc) and reported a discordant, falsely elevated tpsa patient result obtained on a dimension vista 1500 instrument.Siemens headquarters support center (hsc) evaluated the information provided by the customer.The data is consistent with a heterophilic interference which is a limitation listed in the tpsa instructions for use (ifu).The tpsa ifu states: "patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results.This assay has been designed to minimize interference from heterophilic antibodies.Nevertheless, complete elimination of this interference from all patient specimens cannot be guaranteed." hsc requested the patient sample for investigation but no sample was provided.It was concluded that this was not an instrument issue.The event is consistent with the tpsa ifu labeling for the tpsa assay.No potential product issue identified.The instrument continues to be used without issue and the customer is satisfied with the tpsa assay performance.The cause of the event is unknown.The device is performing within specifications.No further evaluation is required.
|
A discordant, falsely elevated total prostate specific antigen (tpsa) result was obtained on a patient serum sample on the dimension vista 1500 instrument.This result was reported to the physician (s).The same sample was reprocessed on an alternate siemens instrument on the same date and a lower, expected result was obtained.There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely elevated tpsa result.
|